Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathophysiology of overactive bladder.

Literature DB >> 22310925

Pathophysiology of overactive bladder.

Mai A Banakhar¹, Tariq F Al-Shaiji, Magdy M Hassouna.

Abstract

Overactive bladder (OAB) is a common disorder that negatively affects the quality of life of our patients and carries a large socioeconomic burden. According to the International Continence Society, it is characterized as urinary urgency, with or without urge incontinence, usually, with frequency and nocturia in the absence of causative infection. The pathophysiology of this disease entity varies between neurogenic, myogenic, or idiopathic factors. This paper provides a review of the contemporary theories behind the pathophysiology of OAB.

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22310925 DOI： 10.1007/s00192-012-1682-6

Source DB: PubMed Journal: Int Urogynecol J ISSN： 0937-3462 Impact factor: 2.894

62 in total

Review 1. The overactive bladder: pharmacologic basis of drug treatment.

Authors: K E Andersson
Journal: Urology Date: 1997-12 Impact factor: 2.649

2. Neurophysiology of stress urinary incontinence.

Authors: Michael B Chancellor; Naoki Yoshimura
Journal: Rev Urol Date: 2004

Review 3. Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis.

Authors: Oscar Fernández
Journal: J Neurol Date: 2002-01 Impact factor: 4.849

Review 4. NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression.

Authors: J S Archer
Journal: Menopause Date: 1999 Impact factor: 2.953

5. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation.

Authors: M A Vizzard; S L Erdman; W C de Groat
Journal: J Comp Neurol Date: 1996-06-24 Impact factor: 3.215

6. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function.

Authors: W D Steers; S Kolbeck; D Creedon; J B Tuttle
Journal: J Clin Invest Date: 1991-11 Impact factor: 14.808

Review 7. What type of urinary incontinence does this woman have?

Authors: Jayna M Holroyd-Leduc; Cara Tannenbaum; Kevin E Thorpe; Sharon E Straus
Journal: JAMA Date: 2008-03-26 Impact factor: 56.272

8. Prevalence and burden of overactive bladder in the United States.

Authors: W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal: World J Urol Date: 2002-11-15 Impact factor: 4.226

Review 9. Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.

Authors: Michelle Jo Semins; Michael B Chancellor
Journal: Nat Clin Pract Urol Date: 2004-12

10. The ultrastructure of bladder lamina propria nerves in healthy subjects and patients with detrusor hyperreflexia.

Authors: Oliver J Wiseman; Ciaran M Brady; Iqbal F Hussain; Prokar Dasgupta; Hilary Watt; Clare J Fowler; David N Landon
Journal: J Urol Date: 2002-11 Impact factor: 7.450

23 in total

Review 1. The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.

Authors: Karl-Erik Andersson; Donna B Boedtkjer; Axel Forman
Journal: Ther Adv Urol Date: 2016-11-04

2. The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue.

Authors: Sasivimol Srisukho; Tawiwan Pantasri; Wirawit Piyamongkol; Chailert Phongnarisorn; Nuntana Morakote
Journal: Int Urogynecol J Date: 2019-06-04 Impact factor: 2.894

3. Liposomal formulations of oxybutynin and resiniferatoxin for the treatment of urinary diseases: improvement of drug tolerance upon intravesical.

Authors: Lorena M D Cirino; Daviane M C Vergne; Gabrielle B Novais; Amanda Cano; Francine F Padilha; Patrícia Severino; Ricardo L C de Albuquerque Júnior; Juliana C Cardoso; Eliana B Souto
Journal: Drug Deliv Transl Res Date: 2021-10-20 Impact factor: 4.617

Review 4. The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Authors: Karl-Erik Andersson; Nurul Choudhury; Jean-Nicolas Cornu; Moses Huang; Cees Korstanje; Emad Siddiqui; Philip Van Kerrebroeck
Journal: Ther Adv Urol Date: 2018-07-06

5. Overactive bladder after female genital mutilation/cutting (FGM/C) type III.

Authors: Jasmine Abdulcadir; Patrick Dällenbach
Journal: BMJ Case Rep Date: 2013-10-04

6. Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.

Authors: G Vijaya; R Cartwright; A Derpapas; P Gallo; R Fernando; V Khullar
Journal: Int Urogynecol J Date: 2013-02-02 Impact factor: 2.894